Press Releases MaaT Pharma accelerates its development with the closing of EUR 1 M in second fundraising Important step in developing microbiome therapy for severe intestinal Dysbiosis.MaaT PharmaJuly 24, 2015
Press Releases MaaT Pharma™ raises EUR 1 M (USD 1.25M) in First Investment Round Financing to develop microbiome therapy for severe intestinal dysbiosisMaaT PharmaJanuary 12, 2015
